Full archive
Pharmacogenomics

Week of 17 November 2026

8 articles

8 articles of 8
CYP2D6
PubMed

A Precise Activity System for Pharmacogenetics Based on Estimation of CYP2D6 Allelic Percentage Activity from the International CEPAM Database

Variability in exposure to CYP2D6-metabolised drugs (model: tamoxifen)
7
Clin Pharmacol Ther 2026· NovRead
Pharmacogenomic variation and medication exposure in a diverse general population
PubMed

Frequency of pharmacogenomic variation and medication exposures among participants in the All of Us Research Program

Pharmacogenomic variation and medication exposure in a diverse general population
7
Sci Transl Med 2026· NovRead
GLP1R
PubMed

Rare GLP1R variants attenuate weight loss with semaglutide but not tirzepatide

Variability in weight loss with GLP-1 receptor agonists
6
Nat Metab 2026· NovRead
Alcohol withdrawal syndrome complicated by seizures
PubMed

Prospective genotype-guided drug selection and dosing in alcohol withdrawal syndrome complicated by seizures: a randomized clinical trial

Alcohol withdrawal syndrome complicated by seizures
6
Dose recommendation
Drug Metab Pers Ther 2026· NovRead
Implementation of pharmacogenomic services in adults aged 65 and over
PubMed

Advancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models

Implementation of pharmacogenomic services in adults aged 65 and over
6
Clin Pharmacol Ther 2026· NovRead
Oncology
PubMed

Pharmacogenomic Determinants of Asparaginase-Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review

Asparaginase toxicities in children: hypersensitivity, pancreatitis, thrombosis, hepatotoxicity
6
OncologyAdverse reaction
Clin Pharmacol Ther 2026· NovRead
CYP3A5
PubMed

The impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant

Tacrolimus pharmacokinetic variability after paediatric heart transplant
5
Dose recommendation
Pharmacogenomics J 2026· NovRead
Psychiatry
medRxiv

Genetic architecture and polygenic prediction of self-reported response to selective serotonin reuptake inhibitors in individuals with depression: a genome-wide meta-analysis

Response to selective serotonin reuptake inhibitors in depression
5
Psychiatry
medRxiv 2026· NovRead